Apollo Endosurgery (APEN) Financials

$10.00

$0.00 (0.00%)

As on 10-Apr-2023 09:30EDT

Market cap

$580 Mln

Revenue (TTM)

$77 Mln

P/E Ratio

--

P/B Ratio

9.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	76.86	62.99	42.05	50.71	60.85	64.31
Cost of Revenue	34.43	28.03	19.81	25.04	27.66	24.58
Gross Profit	42.43	34.96	22.24	25.68	33.19	39.73
Operating Expenses	70.25	54.16	38.04	54.80	65.52	62.17
Operating Profit (EBIT)	-27.82	-19.20	-15.79	-29.12	-40.09	-22.44
Other Income	--	0.14	-1.42	0.41	-1.44	-0.04
Profit before Tax	-39.26	-24.53	-22.47	-27.16	-45.60	-26.99
Provision for Tax	0.58	0.16	0.14	0.28	0.19	0.30
Profit after Tax (Net Income)	-39.84	-24.68	-22.61	-27.43	-45.79	-27.29
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-24.68	-22.61	-27.43	-45.79	-27.29

Liabilities ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	32.59	61.24	6.75	2.12	28.83	49.91
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	38.10	55.81	59.02	19.67	21.19	33.32
Current Liabilities	39.54	14.49	11.67	52.79	24.45	25.83
Total Liabilities	110.23	131.53	77.44	74.58	74.47	109.06

Assets ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	17.35	16.83	18.91	23.58	26.35	51.46
Current Assets	92.88	114.70	58.53	51.00	48.12	57.60
Total Assets	110.23	131.53	77.44	74.58	74.47	109.06
Total Debt*	57.07	53.57	57.89	53.94	21.19	33.32
Net Current Assets	53.34	100.21	46.86	-1.79	23.67	31.77

Cashflow ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	-31.26	-14.45	-20.81	-25.62	-23.12	-13.32
Cash Flow from Investing Activities	--	1.56	1.37	1.04	7.12	-2.14
Cash from Financing Activities	0.35	67.58	25.61	30.51	9.70	26.70
Net Cash Inflow / Outflow	--	54.69	6.17	5.92	-6.31	11.25

Financials Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-0.97	-0.82	-0.98	-1.25	-2.29	-1.95
Cash EPS ($)	-0.90	-0.76	-0.82	-1.06	-1.82	-1.26
Adjusted Book Value ($)	0.79	2.04	0.29	0.10	1.44	3.57
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.76	-0.48	-0.90	-1.16	-1.16	-0.95
Free Cash Flow per Share ($)	-0.83	-0.53	-0.93	-1.21	-1.30	-1.10

Profitability Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	-38.97	-27.51	-37.47	-51.72	-68.72	-33.07
ROE (%)	-84.92	-72.61	-509.60	-177.25	-116.29	-59.12
ROA (%)	-32.96	-23.62	-29.75	-36.81	-49.90	-25.85
EBIT Margin (%)	-36.20	-30.48	-37.56	-57.43	-68.25	-34.96
Net Margin (%)	-51.84	-39.10	-55.66	-53.66	-77.06	-42.47
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	0.22	0.50	-0.17	-0.17	-0.05	-0.01
EBIT Growth (%)	-44.91	-21.56	45.77	29.88	-84.76	0.58
Net Profit Growth (%)	-61.41	-9.16	17.57	40.09	-67.77	33.70
EPS Growth (%)	-0.18	0.16	0.21	0.46	-0.17	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	-10.26	-10.25	-3.46	-2.29	-1.51	-2.87
Price / Book Value	12.54	4.13	11.58	29.53	2.39	1.57
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-14.59	-12.56	-7.40	-3.26	-2.05	-6.36
Close Price ($)	9.97	8.43	3.40	2.85	3.45	5.60
High Price ($)	10.30	10.39	5.15	4.10	9.65	21.88
Low Price ($)	3.49	3.32	1.24	2.50	3.02	3.55
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	1.75	0.87	8.58	25.41	0.73	0.67
Short term debt to equity ratio	0.62	0.01	0.19	16.67	--	0.67
Current Ratio	2.35	7.92	5.02	0.97	1.97	2.23
Quick Ratio	1.89	7.09	4.13	0.80	1.56	1.67
Interest Coverage	-5.96	-2.31	-3.01	-7.19	-10.22	-4.99

Operating Efficiency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	19.51	16.00	19.54	18.20	18.72	18.24
Asset Turnover	0.64	0.60	0.55	0.68	0.66	0.61
Receivable days	59.57	53.05	75.79	74.27	69.38	63.15
Inventory Days	160.26	145.11	176.77	137.10	160.28	196.95
Payable days	63.67	53.81	125.19	183.76	221.97	174.41
Cash Conversion Cycle	156.16	144.35	127.37	27.61	7.69	85.69